W-L HAS ACCESS TO PFIZER COMPOUND FOR CO-PROMOTION FROM LIPITOR AGREEMENT,COULD HELP ASSURE NEW PRODUCT FLOW BEYOND CROWDED 1997-98 PERIOD
Executive Summary
Warner-Lambert is looking at three compounds in the Pfizer pipeline for co-promotion as part of the payback for the Lipitor (atorvastatin) agreement, the company reminded financial analysts during an April 17 session in New York.